Lillian S. Wu
FDA investigator
Appears on 11 documents from 2022 to 2026, most often at sites in California. Most often cites testing and approval or rejection of components, drug product containers, and closures (21 CFR 211.84).
- 11
- Documents on file
- 4.5
- Observations per 483
- 2022
- First seen
- 2026
- Most recent
What they cite most
From 50 observations- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures8
- 21 CFR 211.22Responsibilities of quality control unit6
- 21 CFR 211.100(a)Written procedures; deviations4
- 21 CFR 211.165Testing and release for distribution4
- 21 CFR 211.166Stability testing4
- 21 CFR 211.192Production record review3
Activity by year
2022: 2, 2023: 3, 2024: 2, 2025: 1, 2026: 3
Where
California 3 · India 3 · Alabama 1 · Arizona 1 · Macau 1 · Utah 1
Often inspects with
Is Lillian S. Wu coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
11 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-07-17 | 483 Cascade Specialty Pharmacy, LLCJul 17, 2026 · Poulsbo, Washington | Poulsbo, Washington | 6 | |
| 2026-03-19 | 483 PETNET Solutions IncMar 19, 2026 · Alabama | Alabama | 1 | |
| 2026-02-24 | 483 Pharmalogic Salt Lake City, LLCFeb 24, 2026 · Utah | Utah | 1 | |
| 2025-12-17 | 483 Macau-Union Pharmaceutical LimitedDec 17, 2025 · Macau, Macau | Macau, Macau | 8 | |
| 2024-09-20 | 483 Torrent Pharmaceuticals LimitedSep 20, 2024 · Pithampur, India | Pithampur, India | 1 | |
| 2024-03-01 | 483 Amphastar Pharmaceuticals, Inc.Mar 1, 2024 · Rancho Cucamonga, California | Rancho Cucamonga, California | 6 | |
| 2023-09-08 | 483 OrBion Pharmaceuticals Private LimitedSep 8, 2023 · Sriperumbudur, India | Sriperumbudur, India | 3 |
About this profile
What does Lillian S. Wu inspect?
Lillian S. Wu appears on 11 documents on file covering 11 sites, most often in California.
What do they cite most often?
21 CFR 211.84 (testing and approval or rejection of components, drug product containers, and closures), followed by 21 CFR 211.22 and 21 CFR 211.100(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Lillian S. Wu is dated Jul 17, 2026.